Abuse and misuse of tramadol in patients with non-oncologic pain in a region of Southern Europe.

IF 3.3 Q1 HEALTH POLICY & SERVICES
Journal of Pharmaceutical Policy and Practice Pub Date : 2025-02-07 eCollection Date: 2025-01-01 DOI:10.1080/20523211.2025.2457406
M Perelló, K Rio-Aigé, G Cereza, P Rius, F J Pérez-Cano, M Rabanal
{"title":"Abuse and misuse of tramadol in patients with non-oncologic pain in a region of Southern Europe.","authors":"M Perelló, K Rio-Aigé, G Cereza, P Rius, F J Pérez-Cano, M Rabanal","doi":"10.1080/20523211.2025.2457406","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Tramadol can cause dependence even within the recommended dose range. Its use has increased recently, especially in patients with chronic pain, and although a growing body of literature identifies a non-therapeutic use, patterns of misuse of tramadol is so far limited.</p><p><strong>Methods: </strong>Two-year observational and cross-sectional study (January 2020 - December 2021) was conducted in 75 community pharmacies from Catalonia. To estimate the potential abuse and misuse of tramadol by patients visiting community pharmacy, and to establish the demographic characteristics of the tramadol users, a validated questionnaire based on the Finch criteria was designed. A total of 251 cases were registered.</p><p><strong>Results: </strong>Data show that women were more involved (56.6%) and the highest proportion was found in the age interval of 46-65 years (42.6%). The combination of tramadol and paracetamol was reported in 54.6% of the cases and 73.7% corresponded to immediate-release tablets. In 93.6% of the cases, the request was preceded by previous use. Conversely, young men showed a higher non-prescription request for tramadol, reporting acute pain (<i>p</i> < 0.05). These results indicate that there is non-therapeutic use among patients who visit community pharmacies for information on two profiles.</p><p><strong>Conclusion: </strong>This study shows that being an aged woman and suffering from chronic pain seems to involve a risk of generating dependence on tramadol. Likewise, a suspicion of recreational use of tramadol by young people has also been identified. There is a need to investigate how to manage chronic pain, given its complexity and take into account the risk of misuse that may come with tramadol. The involvement of characteristics such as gender as well as the pharmaceutical form in the development of tramadol misuse also needs to be analysed deeply. It is mandatory to evaluate the criteria for prescribing tramadol and initiatives to improve the knowledge of the health professionals and the population.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"18 1","pages":"2457406"},"PeriodicalIF":3.3000,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809172/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Policy and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20523211.2025.2457406","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Tramadol can cause dependence even within the recommended dose range. Its use has increased recently, especially in patients with chronic pain, and although a growing body of literature identifies a non-therapeutic use, patterns of misuse of tramadol is so far limited.

Methods: Two-year observational and cross-sectional study (January 2020 - December 2021) was conducted in 75 community pharmacies from Catalonia. To estimate the potential abuse and misuse of tramadol by patients visiting community pharmacy, and to establish the demographic characteristics of the tramadol users, a validated questionnaire based on the Finch criteria was designed. A total of 251 cases were registered.

Results: Data show that women were more involved (56.6%) and the highest proportion was found in the age interval of 46-65 years (42.6%). The combination of tramadol and paracetamol was reported in 54.6% of the cases and 73.7% corresponded to immediate-release tablets. In 93.6% of the cases, the request was preceded by previous use. Conversely, young men showed a higher non-prescription request for tramadol, reporting acute pain (p < 0.05). These results indicate that there is non-therapeutic use among patients who visit community pharmacies for information on two profiles.

Conclusion: This study shows that being an aged woman and suffering from chronic pain seems to involve a risk of generating dependence on tramadol. Likewise, a suspicion of recreational use of tramadol by young people has also been identified. There is a need to investigate how to manage chronic pain, given its complexity and take into account the risk of misuse that may come with tramadol. The involvement of characteristics such as gender as well as the pharmaceutical form in the development of tramadol misuse also needs to be analysed deeply. It is mandatory to evaluate the criteria for prescribing tramadol and initiatives to improve the knowledge of the health professionals and the population.

曲马多在南欧地区非肿瘤性疼痛患者中的滥用和误用
背景:曲马多即使在推荐剂量范围内也会引起依赖性。近年来曲马多的使用有所增加,特别是在慢性疼痛患者中,尽管越来越多的文献表明曲马多的非治疗性使用,但迄今为止滥用曲马多的模式有限。方法:对加泰罗尼亚75家社区药店进行为期两年的观察性横断面研究(2020年1月- 2021年12月)。为了评估社区药房患者滥用曲马多的可能性,建立曲马多使用者的人口学特征,设计了一份基于Finch标准的有效问卷。共录得251宗个案。结果:数据显示,女性发病率较高(56.6%),其中46 ~ 65岁年龄组发病率最高(42.6%)。54.6%的病例报告曲马多与扑热息痛合用,73.7%的病例报告曲马多与扑热息痛合用。在93.6%的案例中,请求之前有以前的使用。相反,年轻男性对曲马多的非处方要求更高,报告急性疼痛(p结论:这项研究表明,作为一名老年女性,患有慢性疼痛似乎涉及对曲马多产生依赖的风险。同样,还发现怀疑年轻人娱乐性地使用曲马多。考虑到慢性疼痛的复杂性,并考虑到曲马多可能带来的误用风险,有必要研究如何控制慢性疼痛。性别和药物形式等特征在曲马多滥用发展中的作用也需要深入分析。必须评估曲马多的处方标准以及为提高卫生专业人员和民众的知识而采取的举措。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Pharmaceutical Policy and Practice
Journal of Pharmaceutical Policy and Practice Health Professions-Pharmacy
CiteScore
4.70
自引率
9.50%
发文量
81
审稿时长
14 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信